- Home
- / Beijing Sun-Novo Pharmaceutical Research
Beijing Sun-Novo Pharmaceutical Research
Stock Price
¥44.3
2024-10-29
Market Capitalization
¥4.9 B
2024-10-29
Revenue
¥1.1 B
FY, 2024
Beijing Sun-Novo Pharmaceutical Research Summary
Company Summary
- Overview
- Beijing Sun-Novo Pharmaceutical Research (北京阳光诺和药物研究股份有限公司) is a company that specializes in the research and development of chemical and peptide drugs. It offers clinical research, bioanalysis, data management, pediatric dosing, and other services.
- Type
- Public
- Status
- Active
- Founded
- 2009
- HQ
- CN | view all locations
- Website
- http://www.sun-novo.com
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Bei Jing Shi HQ
China
Beijing Sun-Novo Pharmaceutical Research Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥196.6M
- Gross profit (Q1, 2026)
- ¥96.8M
- Net income (Q1, 2026)
- ¥18.4M
- Cash (Q1, 2026)
- ¥372.4M
- EBIT (Q1, 2026)
- ¥19.1M
- Enterprise value
- $5.2B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026